Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I
NCT01256281 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2015-04-23
Summary
The hypothesis of this study is:
Femoral nerve blocks can feasibly be performed on patients with Sickle Cell Disease and painful crisis in the Emergency Department.
Conditions
Interventions
- PROCEDURE
-
Femoral Nerve Block
Patients enrolled will receive ultrasound guided FNB in addition to standard care. If subjects are experiencing pain in both lower extremities, both extremities will be blocked; if subjects are experiencing pain in one lower extremity, only the affected extremity will be blocked.
Sponsors & Collaborators
-
Icahn School of Medicine at Mount Sinai
lead OTHER
Principal Investigators
-
Jeffrey D Glassberg, MD · Icahn School of Medicine at Mount Sinai
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2013-08-31
- Completion
- 2013-08-31
Countries
- United States
Study Locations
More Related Trials
-
Ketamine Infusion for Acute Sickle Cell Crisis in the Emergency Department
NCT02417298 ·Status: TERMINATED ·Phase: NA
-
Risk-based Therapy for Sickle Cell Anemia: A Feasibility Study
NCT02090296 ·Status: WITHDRAWN ·Phase: PHASE2
-
Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia
NCT04301336 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease
NCT04091737 ·Status: TERMINATED ·Phase: PHASE1
-
Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis
NCT01482091 ·Status: COMPLETED ·Phase: PHASE4
-
Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease
NCT04584528 ·Status: COMPLETED ·Phase: NA
-
Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?
NCT03541980 ·Status: COMPLETED ·Phase: PHASE4
-
Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
NCT03049475 ·Status: COMPLETED
-
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
NCT01197417 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Rejuvesol® Washed RBC in Sickle Cell Patients Requiring Frequent Transfusions
NCT02731157 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo
NCT01419977 ·Status: COMPLETED ·Phase: PHASE2
-
A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease
NCT02620488 ·Status: COMPLETED ·Phase: NA
-
Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease
NCT00004408 ·Status: COMPLETED ·Phase: PHASE3
-
Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell Crisis
NCT03062501 ·Status: UNKNOWN ·Phase: PHASE2
-
Ketamine Sickle Cell Disease
NCT03502421 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study of MGTA-145 and Plerixafor in Patients With Sickle Cell Disease
NCT05445128 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
NCT06546670 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Ultrasound Acute Chest Syndrome Sickle Cell Disease
NCT06880679 ·Status: RECRUITING ·Phase: NA
-
Comparison of Patient Centered Outcomes for People With Sickle Cell Disease in the Acute Care Setting
NCT02411396 ·Status: COMPLETED
-
Steroid Treatment for Sickle Cell Pain Crisis
NCT00263562 ·Status: TERMINATED ·Phase: PHASE3
-
Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
NCT00004492 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005703 ·Status: COMPLETED
-
PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD
NCT04925492 ·Status: RECRUITING ·Phase: PHASE1
-
US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease
NCT04594031 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of Safety and Efficacy of Genome-edited Hematopoietic Stem and Progenitor Cells in Sickle Cell Disease (SCD)
NCT04443907 ·Status: TERMINATED ·Phase: PHASE1